Difference between revisions of "Osteonectin"
m |
|||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 8: | Line 6: | ||
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | - | + | | Basement-membrane protein 40 |
| + | Secreted protein acidic and rich in cysteine | ||
|- | |- | ||
| Determination type | | Determination type | ||
| Line 26: | Line 25: | ||
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| − | | | + | | - |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| Line 35: | Line 34: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 46: | Line 45: | ||
| | | | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:50, 10 March 2015
| Osteonectin | |
|---|---|
| Substrate peptide name | Osteonectin |
| Synonyms | Basement-membrane protein 40
Secreted protein acidic and rich in cysteine |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular |
| Swissprot ID | P09486 |
| Reactive glutamines | Q3, Q4 |
| Reactive lysines | - |
| Substrate sequence | APQQEALPD |
| Structure | 1BMO |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:7559501 |
| Notes | |
